FH:CC - Filament Health announces non-binding agreement for up to US$14 million in financing
(NewsDirect)
Filament Health CEO Ben Lightburn joinedSteve Darling from Proactive to announce the signing of a non-bindingterm sheet for potential funding of up to US$14.4 million. The fundingis in collaboration with an affiliate of Helena Partners Inc., aCayman-Islands-based advisor and investor.
The infusion of capital is expected tosignificantly bolster Filament Health's operations, particularlyin advancing its drug development programs. Furthermore, this fundingwill play a crucial role in facilitating the completion of theProposed Business Combination with the Jupiter AcquisitionCorporation. Notably, it is a strategic step towards achieving thecompany's goal of listing on the Nasdaq stock exchange.
This financial boost demonstrates Filament Health'scommitment to driving innovation in the pharmaceutical sector andexpanding its presence in the financial markets. Stay tuned for moreupdates on Filament Health's exciting journey ahead.
Contact Details
Proactive Investors
+1604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.